Essential character test for intravenous fluids upheld exemption where minor additives did not change replenishment function.

Exemption under Notifications No. 6/2000-C.E. and No. 3/2001-C.E. applied to intravenous fluids where the product's essential composition and function were as replenishment fluids. The Court held that the relevant test was the product's dominant character, not its use in treating a particular disease or in veterinary treatment. Since the goods predominantly contained glucose and electrolytes, and the small quantities of boric acid and chlorocresol did not alter their essential nature, the products remained within the exempt category of life-saving intravenous fluids. The Revenue's challenge failed, and the exemption in favour of the assessees was upheld.

---

---

Issues: Whether the assessees' products, being intravenous fluids with minimal additives, were entitled to exemption under Notification No. 6/2000-C.E. dated 01.03.2000 and Notification No. 3/2001-C.E. dated 01.03.2001 notwithstanding their use in veterinary treatment.

Analysis: The relevant notifications granted exemption to intravenous fluids, and the later notification described them as intravenous fluids used for sugar, electrolyte or fluid replenishment. The decisive test was the composition and essential character of the product, not whether it was used in the treatment of a particular disease. The materials on record showed that the products predominantly contained glucose and electrolytes for replenishment, while the presence of boric acid and chlorocresol was only in minimal proportion and did not change the essential nature of the goods. The products were therefore life-saving intravenous fluids meant for replenishment and remained within the scope of the exemption.

Conclusion: The exemption was available to the assessees, and the challenge by the Revenue failed.

Final Conclusion: The appeals were dismissed, and the exemption granted to the assessees was upheld.

Ratio Decidendi: For exemption notifications covering intravenous fluids, the determining factor is the product's essential composition and function as a replenishment fluid; minor additives do not alter its exempt character unless they change that essential nature.

---